Differentiation of a Falcine Meningioma From Cerebral Venous Sinus Thrombosis Using DOTATATE PET.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 May 2023
01 May 2023
Historique:
medline:
5
4
2023
pubmed:
10
2
2023
entrez:
9
2
2023
Statut:
ppublish
Résumé
Differentiating brain tumors from nonneoplastic lesions using conventional MRI may be challenging. Clinical symptoms often remain unspecific, and imaging findings from MRI may be inconclusive. We present the case of a 23-year-old woman in whom an MRI suggested a cerebral venous sinus thrombosis. On the other hand, additional atypical MRI findings raised doubts regarding the initial diagnosis. Given the need for a diagnostic procedure with higher sensitivity and specificity for neoplastic tissue, PET with the radiolabeled somatostatin receptor ligand DOTATATE ( 68 Ga-DOTA- d -Phe1-Tyr3-octreotate) was performed. DOTATATE PET facilitated the diagnosis of a falcine meningioma consistent with its value for the differential diagnosis of meningioma.
Identifiants
pubmed: 36758554
doi: 10.1097/RLU.0000000000004594
pii: 00003072-202305000-00036
doi:
Substances chimiques
copper dotatate CU-64
0
Organometallic Compounds
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e235-e236Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: The Cologne Clinician Scientist-Program of the Deutsche Forschungsgemeinschaft (FI773/15-1), Germany, supported this work. The authors have no conflicts of interest to report.
Références
Dutour A, Kumar U, Panetta R, et al. Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer . 1998;76:620–627.
Rachinger W, Stoecklein VM, Terpolilli NA, et al. Increased 68 Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J Nucl Med . 2015;56:347–353.
Henze M, Schuhmacher J, Hipp P, et al. PET imaging of somatostatin receptors using [ 68 Ga]DOTA- d -Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med . 2001;42:1053–1056.
Galldiks N, Albert NL, Sommerauer M, et al. PET imaging in patients with meningioma—report of the RANO/PET Group. Neuro Oncol . 2017;19:1576–1587.
Milker-Zabel S, Zabel-du Bois A, Henze M, et al. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [ 68 Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys . 2006;65:222–227.
Nyuyki F, Plotkin M, Graf R, et al. Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas. Eur J Nucl Med Mol Imaging . 2010;37:310–318.
Einhellig HC, Siebert E, Bauknecht HC, et al. Comparison of diagnostic value of 68 Ga-DOTATOC PET/MRI and standalone MRI for the detection of intracranial meningiomas. Sci Rep . 2021;11:9064.
Afshar-Oromieh A, Giesel FL, Linhart HG, et al. Detection of cranial meningiomas: comparison of 68 Ga-DOTATOC PET/CT and contrast-enhanced MRI. Eur J Nucl Med Mol Imaging . 2012;39:1409–1415.
Filizoglu N, Ozguven S. Neurofibromatosis type 2: multiple meningiomatosis and vestibular schwannomas on 68 Ga-DOTATATE PET/CT. Clin Nucl Med . 2022;47:e710–e712.
Pirisino R, Filippi L, D'Agostini A, et al. Management of a patient with metastatic gastrointestinal neuroendocrine tumor and meningioma submitted to peptide receptor radionuclide therapy with 177 Lu-DOTATATE. Clin Nucl Med . 2022;47:e692–e695.
Vay SU, Werner JM, Kabbasch C, et al. Uncovering an optic nerve sheath meningioma using 68 Ga-DOTATATE PET/CT. Clin Nucl Med . 2021;46:e464–e465.